- 1Department of Polymer Engineering, Amirkabir University of Technology, Mahshahr, Iran
- 2Department of Polymer Engineering and Color Technology, Amirkabir University of Technology, Tehran, Iran
- 3Department of Chemistry, Amirkabir University of Technology, Tehran, Iran
- 4Department of Chemical Engineering, Faculty of Petroleum, Gas, and Petrochemical Engineering, Persian Gulf University, Bushehr, Iran
The potential of the nanoscale structure is utilized by electrospun nanofibers, which are promising materials for wound dressings. Here, we prepared wound dressings constituting polycaprolactone (PCL) and chitosan (CS). Curcumin (Cur) and zinc oxide nanoparticles (ZnO) as antibacterial agents were embedded in PCL/CS electrospun nanofibers and different properties including morphology, physicomechanical, interaction with water, antibacterial efficiency, and in vitro studies were investigated. SEM images confirmed the nanofibrous structure of samples with 100 ± 5 to 212 ± 25 nm in average diameter. Elemental analysis of nanofibers showed a good distribution of ZnO along nanofibers which not only caused decreasing in nanofiber diameter but also increased tensile strength of nanofibers up to 2.9 ± 0.5 MPa and with good elongation at break of 39 ± 2.9. ZnO nanoparticles also facilitated the interaction of nanofibers with water, and this led to the highest water vapor transition rate, which was equal to 0.28 ± 0.02 g cm−2 day−1. The sample containing 3 wt% Cur had the highest water uptake value (367 ± 15%) and the lowest water contact angle (78 ± 3.7°), although Cur has a hydrophobic nature. The release profile of Cur showed a two-stage release and the Peppas model predicted a non-fickian diffusion. Simultaneous incorporation of CS, ZnO, and Cur effectively inhibited bacterial growth. In addition, in vitro studies represented that high content of Cur decreases cell viability and cell attachment. The outcomes from the fabricated nanofibrous scaffolds demonstrated appropriate properties for application as a wound dressing.
Introduction
In light of the advancements made in tissue engineering, the topic of electrospinning is gaining popularity in the biomedical world. The high available surface area and high porosity of electrospun nanofibers, being affordable and easy to handle, make electrospun nanofibers an ideal option for wound dressing (Kakoria and Sinha-Ray, 2018; Huang et al., 2022). Electrospun nanofibers can be formed by a range of natural polymers such as cellulose, chitosan (CS), collagen, gelatin, and silk, as well as synthetic biodegradable polymers such as polylactic acid (PLA), polyglycolic acid (PGA), and polycaprolactone (PCL) (Mendes et al., 2017; Zhang et al., 2022).
Electrospinning of pure CS is accompanied by several challenges associated with the limited solubility of pure CS in most organic solvents, its typically large molecular weights, and strong physical networks from hydrogen bonds (Pillai and Sharma, 2009; Qasim et al., 2018). To address this issue, the blending of CS with other natural and synthetic polymers such as polyethylene oxide (PEO), polyvinyl alcohol (PVA), PLA, and collagen have been reported so far. In fact, these polymers, which are well-known for their fiber-forming ability, were used to facilitate the electrospinning of CS (Jia et al., 2007; Chen et al., 2008; Lou et al., 2008; Xu et al., 2009). PCL is an aliphatic semi-crystalline biodegradable polyester known for its good mechanical properties. Being non-toxic and tissue compatible, it has been used in different biomedical applications such as tissue engineering scaffolds, resorbable sutures, and drug delivery (Janmohammadi and Nourbakhsh, 2019; Dwivedi et al., 2020). Nanofibers from pure PCL and its blends with other biopolymers like PLA, gelatin, and polyethylene glycol (PEG) were also produced by many researchers through the electrospinning method (De Prá et al., 2017; Radisavljevic et al., 2018; Janmohammadi and Nourbakhsh, 2019; Semitela et al., 2020).
In recent years, electrospun PCL/CS has received a great deal of attention for the preparation of nanofiber scaffolds (Saatcioglu et al., 2021). PCL/CS nanofibers loaded with tetracycline hydrochloride (TCH) (Ghazalian et al., 2022), azithromycin (Alimohammadi et al., 2022), and metformin (Zhu et al., 2020) and its wound dressing containing aloe vera (Yin and Xu, 2020), Melilotus officinalis (Shahrousvand et al., 2021), and Jaft (Hashemi et al., 2021) have been recently reported in the literature. For instance, Ghazalian et al. (2020) prepared TCH-loaded PCL/CS core-shell nanofibrous structure. The prepared samples demonstrated a two-stage behavior of drug release, with an initial burst release stage followed by a sustained release stage. In another study by Alimohammadi et al. (2020), PCL/CS nanofibers containing azithromycin were prepared via electrospinning which showed a sustained release of the drug with minimized burst release. Zhu et al. (2020) also prepared crosslinked PCL/CS nanofibrous scaffolds as a carrier for the metformin drug. They showed that crosslinked samples were more suitable for drug release, osteogenic differentiation, cell adhesion, and bone mesenchymal stem cells.
In addition, with the development of electrospun nanocomposite scaffolds containing nickel nanoparticles (Karakas et al., 2017), graphene oxide (Aidun et al., 2019), hydroxyapatite (Shirzaei Sani et al., 2021), and multi-walled carbon nanotubes (Mirmusavi et al., 2022) enhanced functional performances of complex nanostructures have been demonstrated. For example, Aidun et al. (2019) investigated the biological activity and physicochemical properties of the PCL/CS scaffolds incorporated with graphene oxide. They found that an increase in nanoparticles corresponded to an increase in the hydrophilicity, bioactivity, cell adhesion, and proliferation of the scaffolds. Sani et al. (Shirzaei Sani et al., 2021) incorporated hydroxyapatite nanoparticles onto PCL/CS nanofibers to enhance their mechanical properties, proliferation, cell viability, and bioactivity of them. In another work, the structural, mechanical, and biological properties of PCL/CS electrospun nanocomposite scaffolds containing multi-walled carbon nanotubes were studied by Mirmusavi et al. (2022). The samples containing nanoparticles showed more cell viability and bioactivity compared to the neat samples. Among these investigations, no research on the Cur drug and ZnO nanoparticles has been seen. Cur is a natural polyphenol with antioxidant, anti-tumor, and anti-inflammatory properties (Afshar et al., 2019; Al-Bishari et al., 2022). The US Food and Drug Administration (FDA) has designated Cur as Generally Recognized As Safe (GRAS) and clinical trials have demonstrated good tolerability and safety profiles even at doses up to 12,000 mg/day of a 95% concentration (Hewlings and Kalman, 2017). Furthermore, ZnO is a multifunctional nanoparticle with effective antimicrobial and photocatalytic properties, biocompatibility as well as being nontoxic and inexpensive. ZnO can also promote the scaffold surface’s hydrophilicity resulting in cell attachment and proliferation (Karthikeyan et al., 2020). It is well known that curcumin can chelate zinc metal ions strongly by acting as a ligand and forming stable complexes. The use of this substance may represent a novel strategy for the early detection and treatment of chronic illnesses (Prasad et al., 2021).
In this study, we electrospun a homogeneous mixture of CS and PCL and evaluated the success of creating nanofibrous scaffolds with the desired morphology. For the first time, Cur and ZnO were simultaneously added to the PCL/CS nanofibrous scaffolds because the antibacterial activity of CS-containing nanofibers is limited by the NH2 groups of the CS backbone (Korniienko et al., 2022). The findings of the investigation into the structural, physicomechanical, and biological characteristics of the prepared scaffolds demonstrated their appropriate properties as wound dressings.
Experimental
Materials
PCL granules with average molecular weight (Mn) of 80,000 g mol−1, and density of 1.145 g cm3, CS with medium molecular weight and degree of deacetylation of 80%–85% (CAS Number: 9012-76-4), Cur drug, Hexafluoroisopropanol (HFIP), 3- [4,5- dimethylthiazol-2-yl]-2,5 diphenyltetrazolium bromide (MTT), Phosphate-buffered saline (PBS), methanol, and ethanol were purchased from Sigma-Aldrich (Germany). ZnO with particles size of 10–30 nm, specific surface area of 20–60 m2 g−1 and purity of 99+% was purchased from US Research Nanomaterials, Inc (United States). The Staphylococcus aureus (S. aureus, ATCC 25,923), Escherichia coli (E. coli, ATCC 25,922), and Fibroblast cells (L929) were purchased from the Pasteur Institute of Tehran (Iran).
Scaffolds fabrication method
To determine the optimum condition of electrospinning a full factorial design experiment was conducted. Additional information is provided in the Supplementary Material (Supplementary Table S1). In brief, it was found that the optimal PCL concentration, CS concentration, flow rate, and voltage were 15 wt%, 3 wt%, 15 kV, and 1 ml h−1, respectively. The needle-to-collector distance and collector speed were fixed at 15 cm and 300 rpm, respectively. To prepare the electrospinning solution, a 15 wt% PCL solution in HFIP was first prepared by stirring (500 rpm) at ambient temperature for 120 min. Then CS was gradually added to the previous solution to reach a total concentration of 3 wt% and stirred (500 rpm) for 90 min. In the case of samples containing Cur and ZnO, they were added to the PCL/CS solution and sonicated for 30 min before electrospinning. A transition from yellow to orange was seen after the sonication process was finished. Finally, the prepared solutions were loaded in a 5 ml syringe with a standard blunt end needle (20 G) in the electrospinning setup. The electrospun nanofibers were placed in an oven for 24 h to dry completely. The sample codes and concentrations are listed in Table 1.
Characterization method
The chemical structure of samples was investigated by attenuated total reflectance Fourier transform spectroscopy (ATR-FTIR). The spectrum was recorded through 64 scans at a resolution of 4 cm−1 and in the range of 600–4000 cm−1 by FTIR spectrometer of Thermo Nicolet Nexus 670 (Madison, WI, United States).
The morphology of scaffold surfaces was evaluated with a scanning electron microscope (SEM, AIS 2100, Seron Technology, South Korea) with an acceleration voltage of 20 kV. The distribution of ZnO nanoparticles incorporated into samples was investigated by using a scanning electron microscope with energy dispersive X-ray spectroscopy (TESCAN. MIRA II, France) with an accelerating voltage of 10 kV.
The physical state of ZnO incorporated in samples was analyzed with X-ray diffraction (XRD, EQuniox 3000, Inel, France) in the 2θ range of 5–80°. Applied radiation was Cu Kα with 40 kV, λ = 0.15418 nm, and 30 mA at room temperature.
To investigate the mechanical properties, 5 replicates of each sample (50 mm × 10 mm × 2 mm) were stretched at a rate of 5 mm min−1 until the fracture point according to ASTM D882 on a universal material testing machine (Instron 5566, United States).
Thermogravimetric analysis was used to assess the thermal behavior of the materials (TGA, Q-500, TA Instruments, United States). Under a nitrogen atmosphere, the pre-weighed samples (15 mg) were heated at a rate of 10°C.min−1 from 25 to 550°C.
The hydrophilicity of the samples was evaluated using the sessile drop method by contact angle goniometer (OCA20, Data Physics Instruments, Germany). To this end, a drop of distilled water was placed on the surface of samples (10 × 10 mm2) using a 0.3 ml syringe. The contact angle of water drop on the surface of the samples was recorded after a few seconds from both sides of the drop. The reported contact angle was the mean of 5 replicates at 5 different sites of a sample.
To evaluate the water uptake behavior of the scaffolds, the samples were accurately weighed and then immersed in distilled water at 37°C. After immersion, the samples were weighed at regular intervals. The percent of water uptake in the samples was calculated based on the Eq. 1 (Ghaee et al., 2019):
Where Wd and Ww represent the weight of dry and submerged samples, respectively.
To investigate the ability to control water loss, the water vapor transmission rate (WVTR) of samples was analyzed according to ASTM E96/E96M-10. The samples covered the opening of the 5 ml glass vial containing 1 ml distilled water. The container was placed in the humidity chamber with a constant temperature of 37°C and humidity of 25% for 48 h. A similar container without any sample was also placed in the humidity chamber as a control. WVTR was calculated using the Eq. 2 (Fahimirad et al., 2021):
Where ΔW is the variation of weight (g) of water before and after the test, A is the exposure area of the samples (cm2), and Δt is the test time (day).
To investigate the in vitro degradation behavior of samples under physiological conditions, the samples (20 × 20 mm2) were immersed in PBS (pH = 7.4) and incubated at 37°C. The PBS solution was refreshed every 48 h. At each time point, the sample was removed from the solution and dried at 50°C. the weight loss of samples was calculated based on the Eq. 3 (Varshosaz et al., 2021):
Where Wi and Wt are the initial dry weight and the final dry weight of the samples (n = 3).
To investigate the release profile of Cur drug, samples (1 × 1 cm2) were immersed in 5 ml of PBS (pH = 7.4) and incubated at 37°C. At specific time points, 1 ml of the media was extracted and replaced with 1 ml of fresh media. To determine the concentration of the sample, 5 solutions of Cur were prepared with different concentrations, and their maximum absorbance at 425 nm was measured by UV-Vis (Secomam, France).
The Eq. 4 was used to fit Peppas’ model to the experimental data to study the kinetics of Cur release from electrospun nanofibers (Lao et al., 2008):
Where K and t are the kinetic constant and release exponent, and Mt and M∞ are the amount of drug released at time t and the total amount of drug, respectively.
The antibacterial activity of samples was investigated using two types of bacteria, a Gram-positive (S. aureus) and a Gram-negative (E. coli) according to agar diffusion method at 37°C. The strip-shaped samples (20
Where OD1 and OD2 are the optical densities of the control medium and the bacteria in the solution-containing sample, respectively.
Cell viability of samples was investigated by MTT assay in direct mode. First, samples were sterilized using Gama radiation with a dose of 15 kGy. Suspensions of L929 cell line were seeded on the sterilized samples with a density of 5 × 104 cells per well and stored in an incubator (at 37°C, 5% CO2, and 90% humidity). After 24 h, the medium of each well was replaced with 200 μL of 0.5% MTT solution and incubated for 4 h. The MTT solution of each well was replaced with 150 µL isopropanol and the absorbance was read by ELISA at wavelengths of 490 and 630 nm as reference. Cell viability of samples was calculated by the Eq. 6 (Ghaee et al., 2019):
Where ODs and ODc are absorption of sample and control, respectively.
To investigate cell adhesion of samples, after 7 days of seeding cells on them, the media was extracted. The cells were fixed with glutaraldehyde (2.5% v/v) for 24 h. Then samples were dried with a series of ethanol solutions from 10 to 100% v/v and coated with gold to prepare for SEM analysis.
Results and discussion
Fourier transform spectroscopy analysis
The result of ATR-FTIR is shown in Figure 1 for pure PCL, CS, ZnO, Cur, and the electrospun nanofibers. Characteristic peaks of PCL include peaks at 733, 1294, 1469, and 1725 cm−1 which are attributed to C-O stretching, asymmetric stretching of C-O-C bridge, CH2 deformation, and carbonyl ester bonds (C=O), respectively (Ghaee et al., 2019). CS also showed its main characteristic peaks at 897, 1080, 1151, 1652 cm−1, 2922 cm−1, and 3423 cm−1, which belong to the CH3OH groups, C-O stretching, asymmetric stretching of C-O-C bridge, N-H bending, C-H stretching, and O-H stretching, respectively (Ghazalian et al., 2022). The characteristic peaks of PCL and CS exist in the FTIR of electrospun nanofiber of PCL15CS3. However, they shifted slightly due to the electrostatic interaction of PCL with CS. Also, the peaks at 2900 cm−1 and 1600 cm−1 belong to the stretching of C-H and bending of N-H, respectively. The peak at 1110 cm−1 is attributed to the C-O-C bridge.
The main characteristic peak of ZnO is located in the range of 500–700 cm−1 indicates the stretching of the Zn–O bond. The peak around 800 cm−1 can be attributed to the stretching vibration mode of Zn-O-Zn (Babaei et al., 2022). The main characteristic peaks of Cur are attributed to the aromatic peaks. Cur exhibits peaks at 822 cm−1 and 1020 cm−1 that are related to C-H aromatic in-plane bending modes and out-of-plane bending, respectively. The peaks at 1280, 1408,1510, and 1626 cm−1 belong to C–O–C stretching, aromatic C–O stretching, C=O stretching and C–C symmetric aromatic ring stretching, respectively (Ghaee et al., 2019). Characteristic peaks of ZnO and Cur are present with a shifted position in the spectrum of electrospun nanofibers containing them, confirming their presence.
Scanning electron microscope images of samples
Figure 2 shows the SEM images of electrospun nanofibers and their diameter distribution histograms. All samples had uniform bead-free morphology. The pure PCL nanofibers showed smooth morphology with an average diameter of 212 ± 25 nm. The addition of CS decreased the diameter of nanofibers by about 186 ± 18 nm. The CS increases the polarity of electrospinning solution due to its charged functional groups that cause the stretching of fibers under an electrical field (Van der Schueren et al., 2012; Bolaina-Lorenzo et al., 2016). Moreover, ZnO nanoparticles increase conductivity of solution and cause more drawn. It can be seen that the PCL15CS3ZnO1 sample had the lowest average fiber diameter (100 ± 5 nm). The ZnO nanoparticles are also shown by the yellow arrow that have a good distribution state. The Cur drug affects viscosity more than conductivity. This increased solution viscosity led to increased average fiber diameters by 130 ± 10 and 150 ± 15 nm for nanofibers with 1 and 3 wt% Cur, respectively (Mitra et al., 2022).
FIGURE 2. SEM images of the electrospun nanofibers and their diameter distribution histograms, (A) PCL15, (B) PCL15CS3, (C) PCL15CS3ZnO1, (D) PCL15CS3ZnO1Cur1, and (E) PCL15CS3ZnO1Cur3.
Elemental analysis of samples
The elemental maps of pure PCL15CS3 electrospun nanofibers and its composites containing ZnO and Cur are demonstrated in Figure 3. In these maps, zinc as the characteristic element of ZnO, and O, C, and N elements were detected. Based on this elemental map, ZnO nanoparticles (yellow points show Zn element) distributed homogeneously in samples of PCL15CS3ZnO1-Cur1 and PCL15CS3ZnO1Cur3. The obtained data from this analysis are also shown in Table 2.
X-ray diffraction analysis of samples
The XRD pattern of ZnO, Cur, and the electrospun nanofibers is shown in Figure 4. The X-ray diffractogram of ZnO showed several strong and sharp peaks at 2θ of 31.84°, 34.52°, 36.33°, 47.63°, 56.71°, and 68.13° which are related to planes of 100, 002, 101, 102, 110, and 112 and confirm the hexagonal structure of ZnO nanoparticles. The peak occurred at 34.52° is responsible the antibacterial capability of ZnO (Tajdari et al., 2021; Babaei et al., 2022). The exhibition of sharp peaks at 2θ of 17.3°, 21.3°, 23.4°, and 24.7° indicates high crystallinity of Cur (Rahimi et al., 2017).
The PCL15 nanofibers show two characteristic peaks at 2θ of 21.4° and 23.8° (Pekdemir et al., 2021). Although these two peaks appear in all electrospun nanofibers, they are slightly shifted to lower 2θ, which means PCL retained its crystallinity. By adding ZnO and Cur, the crystallinity of electrospun nanofibers was decreased due to the interaction of ZnO and Cur with the polymeric phase, which decreased the intensity of crystalline peaks in the PCL15CS3ZnO1Cur3 scaffold. The reduced mobility of polymer segments by CS and the blending of the elements in the amorphous phase can both contribute to the reduction of PCL crystallinity (Karthikeyan et al., 2020).
Mechanical behavior of samples
Electrospun nanofibers must possess appropriate mechanical properties especially elongation at break for wound dressing applications. It implies that a wound dressing must meet certain criteria to cover the wound without rupturing during the healing process. Figure 5 illustrates tensile stress-strain curves for electrospun nanofibers. The obtained results from the tensile test are summarized in Table 3. The tensile strength of electrospun nanofibers was between 1.9 ± 0.2 and 2.9 ± 0.5 MPa, which is in a good range for wound dressing application. Pure PCL15 nanofibers showed the lowest tensile strength and highest elongation at break (1.9 ± 0.2 MPa and 54 ± 3.2%, respectively). By blending PCL with CS, although the tensile strength increased to some extent (2.2 ± 0.3 MPa) compared to pure PCL15, but caused a decrease in elongation at break (43 ± 3.6%).
The high mechanical strength of ZnO as an inorganic phase and forming hydrogen bonds with the polymeric phase caused the highest tensile strength and modulus for PCL15CS3ZnO1 (2.9 ± 0.5 MPa and 0.32 ± 0.04 MPa) compared to other samples. The results also revealed that Cur weakened the mechanical properties of electrospun nanofibers in a dose-dependent manner. The tensile strength, tensile modulus, and elongation at break of the nanofibrous scaffold containing 1 and 3 wt% Cur were 2.5 ± 0.4 and 2.6 ± 0.3 MPa, 0.18 ± 0.03 and 0.22 ± 0.02 MPa and 25 ± 2.2 and 22 ± 1.6%, respectively.
Thermogravimetric analysis analysis of samples
The TGA curve of samples up to 550°C is shown in Figure 6. As can be seen, the thermogram of CS shows two-stage weight loss. The first decay happened at about 90°C due to the evaporation of intercalated or crystal moisture in the CS network, which was about 10% of the sample’s initial weight. In the second stage, about 60% of the weight of CS is lost, which is related to the breakdown of glycosidic bonds and the breakdown of CS chains consequently (Wanjun et al., 2005; Afshar et al., 2019). In addition, pure PCL15 has good thermal stability with the starting point of degradation about 230°C due to aliphatic polyester groups and its semi-crystalline structure (Pekdemir et al., 2021). By blending CS with PCL, the thermal stability of electrospun nanofibers decreased in comparison with pure CS and PCL15. The PCL15CS3 showed the lowest thermal stability and decomposition temperature (about 160–275°C) compared to other electrospun nanofibers.
The addition of ZnO shifted starting point of degradation to higher temperatures (from 160°C to about 200°C). The ZnO nanoparticles are inorganic compounds with high thermal conductivity that accelerates heat transfer to other parts of the electrospun nanofibers and delays degradation. The effect of 1 wt% Cur on the thermal degradation of electrospun nanofibers is negligible, but for 3 wt% Cur an enhancement is shown. Notably, thermogravimetric analysis of the nanofibers verified the lack of HFIP solvent in them (boiling point = 58.2°C), which guarantees the biocompatibility of electrospun nanofibers.
Water contact angle
The contact angle between the water and the wound dressing provides useful information about the in vivo interaction between the surface of the damaged tissue and the wound dress. In general, increasing the hydrophilicity of the wound dressing surface leads to facilitated and improved cell adhesion and proliferation. The water contact angle (WCA) values of electrospun nanofibers are summarized in Table 4. The contact angle of PCL with water was about 118 ± 6.7° which is expected due to the hydrophobicity nature of PCL (Bolaina-Lorenzo et al., 2016). The addition of CS significantly increased the surface hydrophilicity of PCL nanofibers, which is thanks to the amino ester and hydroxyl groups in the CS chains (97 ± 5.1°). The ZnO also helped WCA decreases to 95 ± 4.5° because of increasing roughness and forming hydrogen bonds with water molecules. Although Cur does not dissolve in water, its oxygen can interact with water and serve as a proton donor. Therefore, the addition of Cur caused the nanofibers to become more hydrophilic and reduced the contact angle (Pulla Reddy et al., 1999; Nandhini et al., 2020).
Water uptake
The results of water uptake are summarized in Figure 7. To manage wound dryness and transfer nutrients and waste, optimum water uptake is necessary for wound dressing nanofibers. Water uptake of samples was about 210–370% which is appropriate for wound dressing. The pure PCL15 nanofibers had the lowest water uptake (212 ± 11%) compared to other samples, which is due to the hydrophobicity of t (Pekdemir et al., 2021). Notably, the water uptake capacity of a scaffold is influenced by several parameters such as including the polymer’s crystallinity, porosity, and hydrophilicity. The water uptake rises with increased amorphous area and porosity as a result of facilitated water penetration in micro and macro states. As can be seen, PCL15CS3 nanofibers had a greater water uptake compared to pure PCL15. This was caused by the hydrophilicity and amorphousness of the CS chains in comparison to PCL. This increases their affinity for water molecules and the porous structure of the CS-containing electrospun nanofibers, which allows water to be absorbed through the capillary effect. (Bolaina-Lorenzo et al., 2016; Fahimirad et al., 2021). ZnO nanoparticles increased water uptake of electrospun nanofibers by creating hydrogen bonds with water molecules. Although Cur has a hydrophobic nature, its hydrogen interactions with CS increase water uptake. The highest water uptake value (367 ± 15%) was achieved for PCL15CS3ZnO1Cur3.
Water vapor transmission rate results
A dry wound or a wound infection can result from an imbalance of moisture and secretions between the wound dressing and the wound. To determine the gas exchange to the wound site, the WVTR of electrospun samples was investigated and summarized in Figure 8. According to the results, the presence of CS in the PCL15CS3 led to an increase in WVTR compared to pure PCL15 due to more hydrophilicity, amorphousness, and porosity. In WVTR, the porosity plays a more impressive role compared to hydrophilicity and amorphousness. Due to the increased scaffold porosity that resulted from a decrease in the nanofiber diameter (see Figure 2), WVTR has increased in the case of PCL15CS3ZnO1. Additionally, water vapor molecules and ZnO nanoparticles interact electrostatically, increasing water vapor permeability in contrast, in the case of nanofibers containing Cur, an increase in the nanofiber diameter results in a decrease in the scaffold porosity, which in turn causes a decrease in WVTR (Fahimirad et al., 2021). Besides, the WVTR was further reduced as Cur content was increased. Altogether, the results obtained from the fabricated nanofiber scaffolds proved appropriate water uptake and WVTR properties for application as a wound dressing.
In vitro degradation
Figure 9 shows the degradation behavior of electrospun nanofibers during 50 days. Based on the literature, the long linear aliphatic polyester structure of PCL slows down its degradation rate which is consistent with the results of the pure PCL15 sample (Sun et al., 2006). Due to the NH2 and OH groups that are found along the CS chains, which improve its hydrophilicity, CS can significantly contribute to boosting the degradation of electrospun nanofibers. In the other words, CS chains leak out of the scaffolds by dissolving in water over time (Sun et al., 2006). The effect of ZnO and 1 wt % Cur on the degradation of PCL15CS3 can be ignored, but PCL15CS3ZnO1Cur3 had the highest degradation.
In vitro release of Cur
Figure 10 illustrates the cumulative release profile of Cur drug in electrospun nanofibers with 1 and 3 wt% Cur. According to the results, both nanofibers present a two-stage Cur release, a burst release followed by a steady one. The burst release of PCL15CS3ZnO1Cur3 (34 ± 2.3 and 52 ± 5.5% of Cur in the first 2 and 6 h) is more than PCL15CS3ZnO1Cur1 (26 ± 3.3 and 45 ± 5.2% of Cur in the first 2 and 6 h) due to higher Cur content. The release of Cur at the beginning of the steady release stage (during 24 h) was 65 ± 4.2 and 55 ± 3.1% for PCL15CS3ZnO1Cur3 and PCL15CS3ZnO1Cur1, respectively. After 72 h, electrospun nanofibers of PCL15CS3ZnO1Cur3 and PCL15CS3ZnO1Cur1 released 76 ± 2.8 and 65 ± 3.1% of Cur, respectively.
FIGURE 10. Release profile with their fitted Peppas model of the Cur-containing electrospun samples.
Finally, six models were used to analyze the kinetics of drug release, which are listed in the Supplementary Material (Supplementary Table S2). The results of fitting for each model are summarized in Table 5. Among the presented models, the Peppas one had the highest correlation coefficient (R2) and the best fitting (See Figure 10). The plots for other curve-fitting analysis are displayed in the Supplementary Material (Supplementary Figures S1–S5). Based on the Peppas model, the exponent (n) is used for describing the release mechanisms. n = 0.5 characterizes typical Fickian diffusion, whereas n = 1 describes case II diffusion. A non-Fickian is indicated by n values between 0.5 and 1. Predicted n exponents for both samples are below 0.5 which reveals the mechanism of drug release from electrospun nanofibers is non-Fickian diffusion (Shahrousvand et al., 2022). The correlation coefficients of the model for two Cur-containing samples was 0.93 and 0.95, indicating that the model fits the experimental data reasonably well.
TABLE 5. Parameters of different kinetic models for the release profile of Cur-containing electrospun samples.
Antibacterial efficiency of samples
The antibacterial activity of electrospun nanofibers against two types of bacteria, Escherichia coli (E. coli) and Staphylococcus aureus (S. aureus), was investigated (Figure 11). As expected, pure PCL15 did not show any inhibition. The results showed that the incorporation of CS into the PCL scaffold was effective in increasing the antibacterial efficiency against both bacteria. The PCL15CS3 scaffold had an antibacterial efficiency of 24.1 ± 2.1 and 35.3 ± 1.3 against E. coli and S. aureus, respectively. This is due to the interaction of NH2 groups of CS with PCL chains. Moreover, CS is an effective natural antibacterial agent against both bacteria and chitosan’s positive charge interacts with the negatively charged cell membranes to kill bacteria (Ono et al., 2000; Zou et al., 2020).
FIGURE 11. Antibacterial efficiency of the electrospun samples against E. coli and S. aureus bacteria after 24 h.
ZnO nanoparticles had different effects on the antibacterial activity of the scaffolds against bacteria, increasing antibacterial activity against E. coli while decreasing antibacterial effectiveness against S. aureus. It means that ZnO had a better performance against E. coli bacteria, which is due to their thin-walled nature (Bakhsheshi-Rad et al., 2021; Keyvani et al., 2021). Incorporation of Cur to PCL15CS3ZnO1 produced greater antibacterial activity against both bacteria. For example, PCL15CS3ZnO1Cur3 provided an antibacterial efficiency of 49.2 ± 5.8 and 59.3 ± 3.9% against E. coli and S. aureus bacteria, respectively. These findings demonstrated that all nanofibers had appropriate antibacterial activity, making them viable scaffolds for use in wound dressings.
MMT and cell adhesion assay
In order to study the cell viability of electrospun scaffolds, L929 cells were cultured directly on the nanofibers for 24 h. The cell viability of electrospun nanofibers is shown in Figure 12. In the case of Cur-free samples, cell viability was greater than 80%, demonstrating that there was no cytotoxicity. However, cell viability is decreased by the addition of ZnO and Cur. In other words, Cur inhibited the proliferation and survival of L929 cells in a dose-dependent manner.
The cell morphology on the electrospun nanofibers is illustrated in Figure 13. Despite the pure PCL15 sample having high cell adhesion, there were undesirable cell distributions on the electrospun mat. The increase in cell adhesion on PCL15CS3 nanofibers is due to the polysaccharide structure of CS and its higher hydrophilicity compared to PCL. Cell shrinking and the spherical phenotype of cells are early signs of apoptosis. According to this phenomenon, ZnO nanoparticles and Cur decreased cell adhesion and cell distribution which is in agreement with MTT results.
FIGURE 13. SEM images of L 929 fibroblast cells on the electrospun nanofibers of (A) PCL15, (B) PCL15CS3, (C) PCL15CS3ZnO1, (D) PCL15CS3ZnO1Cur1, and (E) PCL15CS3ZnO1Cur3 after 7 days cell seeding.
Conclusion
In this study, the PCL and CS mixture was successfully electrospun using a 15 wt% PCL and a 3 wt% CS in HFIP solvent to improve the hydrophilicity of PCL nanofibers for use in wound dressing applications. Afterward, Cur and ZnO were incorporated into the electrospun nanofibers, and their structural, physicomechanical, antibacterial activity, and in vitro properties were investigated. SEM analysis showed smooth nanofibers with a bead-free morphology. The elemental analysis also proved a good distribution of ZnO in scaffolds. By adding ZnO, WVTR and nanofibers’ tensile characteristics were significantly improved, while the highest water uptake value was achieved for the sample containing 3 wt% Cur. The Cur drug released rapidly and reached a steady state about 24 h. The Peppas model provided the best fitting results on experimental data. Simultaneous incorporation of Cs, ZnO, and Cur effectively inhibited bacterial growth. The outcomes showed that electrospun nanofibers made of PCL, CS, ZnO, and Cur had a high potential for use as wound dressings.
Data availability statement
The original contributions presented in the study are included in the article/Supplementary Material, further inquiries can be directed to the corresponding author.
Author contributions
PM: Investigation, data curation, formal analysis, writing-original draft, HN: Methodology, conceptualization, supervision, project administration, ZA: Methodology, conceptualization, supervision, AR: Conceptualization, validation, formal analysis, Writing—review and editing.
Conflict of interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Supplementary material
The Supplementary Material for this article can be found online at: https://www.frontiersin.org/articles/10.3389/fbioe.2022.1027351/full#supplementary-material
References
Afshar, S., Rashedi, S., Nazockdast, H., and Ghazalian, M. (2019). Preparation and characterization of electrospun poly (lactic acid)-chitosan core-shell nanofibers with a new solvent system. Int. J. Biol. Macromol. 138, 1130–1137. doi:10.1016/j.ijbiomac.2019.07.053
Aidun, A., Safaei Firoozabady, A., Moharrami, M., Ahmadi, A., Haghighipour, N., Bonakdar, S., et al. (2019). Graphene oxide incorporated polycaprolactone/chitosan/collagen electrospun scaffold: Enhanced osteogenic properties for bone tissue engineering. Artif. Organs 43 (10), E264–E81. doi:10.1111/aor.13474
Al-Bishari, A. M., Al-Shaaobi, B. A., Al-Bishari, A. A., Al-Baadani, M., Yu, L., Shen, J., et al. (2022). Vitamin D and curcumin-loaded PCL nanofibrous for engineering osteogenesis and immunomodulatory scaffold. Front. Bioeng. Biotechnol. 10, 975431. doi:10.3389/fbioe.2022.975431
Alimohammadi, M., Fakhraei, O., Moradi, A., Kabiri, M., Moradi, A., Passandideh-Fard, M., et al. (2022). Controlled release of azithromycin from polycaprolactone/chitosan nanofibrous membranes. J. Drug Deliv. Sci. Technol. 71, 103246. doi:10.1016/j.jddst.2022.103246
Babaei, A., Haji Abdolrasouli, M., and AjjoTCM, R. (2022). Polylactic acid/polycaprolactone bionanocomposites containing zinc oxide nanoparticles: Structure, characterization and cytotoxicity assay. J. Thermoplast. Compos. Material 2022, 08927057221118823. doi:10.1177/08927057221118823
Bakhsheshi-Rad, H. R., Hamzah, E., Ying, W. S., Razzaghi, M., Sharif, S., Ismail, A. F., et al. (2021). Improved bacteriostatic and anticorrosion effects of polycaprolactone/chitosan coated magnesium via incorporation of zinc oxide. Materials 14 (8), 1930. doi:10.3390/ma14081930
Bolaina-Lorenzo, E., Martínez-Ramos, C., Monleón-Pradas, M., Herrera-Kao, W., Cauich-Rodríguez, J. V., and Cervantes-Uc, J. M. J. B. M. (2016). Electrospun polycaprolactone/chitosan scaffolds for nerve tissue engineering: Physicochemical characterization and schwann cell biocompatibility. Biomed. Mat. 12 (1), 015008. doi:10.1088/1748-605x/12/1/015008
Chen, Z., Mo, X., He, C., and Wang, H. (2008). Intermolecular interactions in electrospun collagen–chitosan complex nanofibers. Carbohydr. Polym. 72 (3), 410–418. doi:10.1016/j.carbpol.2007.09.018
Chen, H., Xing, X., Tan, H., Jia, Y., Zhou, T., Chen, Y., et al. (2017). Covalently antibacterial alginate-chitosan hydrogel dressing integrated gelatin microspheres containing tetracycline hydrochloride for wound healing. Mater. Sci. Eng. C 70, 287–295. doi:10.1016/j.msec.2016.08.086
De Prá, M. A. A., Ribeiro-do-Valle, R. M., Maraschin, M., and Veleirinho, B. (2017). Effect of collector design on the morphological properties of polycaprolactone electrospun fibers. Mater. Lett. 193, 154–157. doi:10.1016/j.matlet.2017.01.102
Dwivedi, R., Kumar, S., Pandey, R., Mahajan, A., Nandana, D., Katti, D. S., et al. (2020). Polycaprolactone as biomaterial for bone scaffolds: Review of literature. J. Oral Biol. Craniofacial Res. 10 (1), 381–388. doi:10.1016/j.jobcr.2019.10.003
Fahimirad, S., Abtahi, H., Satei, P., Ghaznavi-Rad, E., Moslehi, M., and Ajcp, G. (2021). Wound healing performance of PCL/chitosan based electrospun nanofiber electrosprayed with curcumin loaded chitosan nanoparticles. Carbohydr. Polym. 259, 117640. doi:10.1016/j.carbpol.2021.117640
Ghaee, A., Bagheri-Khoulenjani, S., Afshar, H. A., and Bogheiri, H. (2019). Biomimetic nanocomposite scaffolds based on surface modified PCL-nanofibers containing curcumin embedded in chitosan/gelatin for skin regeneration. Compos. Part B Eng. 177, 107339. doi:10.1016/j.compositesb.2019.107339
Ghazalian, M., Afshar, S., Rostami, A., Rashedi, S., and Bahrami, S. H. (2022). Fabrication and characterization of chitosan-polycaprolactone core-shell nanofibers containing tetracycline hydrochloride. Colloids Surfaces A Physicochem. Eng. Aspects 636, 128163. doi:10.1016/j.colsurfa.2021.128163
Hashemi, S-S., Saadatjo, Z., Mahmoudi, R., Delaviz, H., Bardania, H., Rajabi, S-S., et al. (2021). Preparation and evaluation of polycaprolactone/chitosan/Jaft biocompatible nanofibers as a burn wound dressing. Burns 4179, 00362–00364. doi:10.1016/j.burns.2021.12.009
Hewlings, S. J., and Kalman, D. S. J. F. (2017). Curcumin: A review of its effects on human health. Foods 6 (10), 92. doi:10.3390/foods6100092
Huang, C., Xu, X., Fu, J., Yu, D-G., and Liu, Y. J. P. (2022). Recent progress in electrospun polyacrylonitrile nanofiber-based wound dressing. Polym. (Basel). 14 (16), 3266. doi:10.3390/polym14163266
Janmohammadi, M., and Nourbakhsh, M. (2019). Electrospun polycaprolactone scaffolds for tissue engineering: A review. Int. J. Polym. Mater. Polym. Biomaterials 68 (9), 527–539. doi:10.1080/00914037.2018.1466139
Jia, Y-T., Gong, J., Gu, X-H., Kim, H-Y., Dong, J., and Shen, X-Y. (2007). Fabrication and characterization of poly (vinyl alcohol)/chitosan blend nanofibers produced by electrospinning method. Carbohydr. Polym. 67 (3), 403–409. doi:10.1016/j.carbpol.2006.06.010
Kakoria, A., and Sinha-Ray, S. (2018). A review on biopolymer-based fibers via electrospinning and solution blowing and their applications. Fibers 6 (3), 45. doi:10.3390/fib6030045
Karakas, K., Celebioglu, A., Celebi, M., Uyar, T., and Zahmakiran, M. (2017). Nickel nanoparticles decorated on electrospun polycaprolactone/chitosan nanofibers as flexible, highly active and reusable nanocatalyst in the reduction of nitrophenols under mild conditions. Appl. Catal. B Environ. 203, 549–562. doi:10.1016/j.apcatb.2016.10.020
Karthikeyan, C., Varaprasad, K., Akbari-Fakhrabadi, A., Hameed, A. S. H., and Rjcp, S. (2020). Biomolecule chitosan, curcumin and ZnO-based antibacterial nanomaterial, via a one-pot process. Carbohydr. Polym. 249, 116825. doi:10.1016/j.carbpol.2020.116825
Keyvani, A., Zamani, M., Bahamirian, M., Nikoomanzari, E., Fattah-alhosseini, A., and Sina, H. (2021). Role of incorporation of ZnO nanoparticles on corrosion behavior of ceramic coatings developed on AZ31 magnesium alloy by plasma electrolytic oxidation technique. Surfaces Interfaces 22, 100728. doi:10.1016/j.surfin.2020.100728
Korniienko, V., Husak, Y., Radwan-Pragłowska, J., Holubnycha, V., Samokhin, Y., Yanovska, A., et al. (2022). Impact of electrospinning parameters and post-treatment method on antibacterial and antibiofilm activity of chitosan nanofibers. Molecules 27 (10), 3343. doi:10.3390/molecules27103343
Lao, L. L., Venkatraman, S. S., and Peppas, N. A. (2008). Modeling of drug release from biodegradable polymer blends. Eur. J. Pharm. Biopharm. 70 (3), 796–803. doi:10.1016/j.ejpb.2008.05.024
Lou, C-W., Lin, J-H., Yen, K-C., Lu, C-T., and Lee, C-Y. (2008). Preparation of polyethylene oxide/chitosan fiber membranes by electrospinning and the evaluation of biocompatibility. Text. Res. J. 78 (3), 254–257. doi:10.1177/0040517507089752
Mendes, A. C., Stephansen, K., and Chronakis, I. S. J. F. H. (2017). Electrospinning of food proteins and polysaccharides. Food Hydrocoll. 68, 53–68. doi:10.1016/j.foodhyd.2016.10.022
Mirmusavi, M. H., Ahmadian, M., and Karbasi, S. (2022). Polycaprolactone-chitosan/multi-walled carbon nanotube: A highly strengthened electrospun nanocomposite scaffold for cartilage tissue engineering. Int. J. Biol. Macromol. 209, 1801–1814. doi:10.1016/j.ijbiomac.2022.04.152
Mitra, S., Mateti, T., Ramakrishna, S., and Laha, A. J. J. (2022). A review on curcumin-loaded electrospun nanofibers and their application in modern medicine. JOM (1989) 74 (9), 3392–3407. doi:10.1007/s11837-022-05180-9
Nandhini, G., Nivedha, B., Pranesh, M., and Karthega, M. (2020). Study of polycaprolactone/curcumin loaded electrospun nanofibers on AZ91 magnesium alloy. Mater. Today Proc. 33, 2170–2173. doi:10.1016/j.matpr.2020.03.327
Ono, K., Saito, Y., Yura, H., Ishikawa, K., Kurita, A., Akaike, T., et al. (2000). Photocrosslinkable chitosan as a biological adhesive. J. Biomed. Mat. Res. 49 (2), 289–295. doi:10.1002/(sici)1097-4636(200002)49:2<289:aid-jbm18>3.0.co;2-m
Pekdemir, M. E., Öner, E., Kök, M., and Qader, I. (2021). Thermal behavior and shape memory properties of PCL blends film with PVC and PMMA polymers. Iran. Polym. J. 30 (6), 633–641. doi:10.1007/s13726-021-00919-8
Pillai, C., and Sharma, C. P. (2009). Electrospinning of chitin and chitosan nanofibres. Trends Biomater. Artif. Organs 22 (3), 179–201.
Prasad, S., DuBourdieu, D., Srivastava, A., Kumar, P., and Lall, R. (2021). Metal–curcumin complexes in therapeutics: An approach to enhance pharmacological effects of curcumin. Int. J. Mol. Sci. 22 (13), 7094. doi:10.3390/ijms22137094
Pulla Reddy, A. C., Sudharshan, E., Appu Rao, A., and Lokesh, B. J. L. (1999). Interaction of curcumin with human serum albumin—A spectroscopic study. Lipids 34 (10), 1025–1029. doi:10.1007/s11745-999-0453-x
Qasim, S., Zafar, M., Najeeb, S., Khurshid, Z., Shah, A., Husain, S., et al. (2018). Electrospinning of chitosan-based solutions for tissue engineering and regenerative medicine. Int. J. Mol. Sci. 19 (2), 407. doi:10.3390/ijms19020407
Radisavljevic, A., Stojanovic, D. B., Perisic, S., Djokic, V., Radojevic, V., Rajilic-Stojanovic, M., et al. (2018). Cefazolin-loaded polycaprolactone fibers produced via different electrospinning methods: Characterization, drug release and antibacterial effect. Eur. J. Pharm. Sci. 124, 26–36. doi:10.1016/j.ejps.2018.08.023
Rahimi, M., Valeh-e-Sheyda, P., and Rashidi, H. (2017). Statistical optimization of curcumin nanosuspension through liquid anti-solvent precipitation (LASP) process in a microfluidic platform: Box-Behnken design approach. Korean J. Chem. Eng. 34 (11), 3017–3027. doi:10.1007/s11814-017-0201-3
Saatcioglu, E., Ulag, S., Sahin, A., Yilmaz, B. K., Ekren, N., Inan, A. T., et al. (2021). Design and fabrication of electrospun polycaprolactone/chitosan scaffolds for ligament regeneration. Eur. Polym. J. 148, 110357. doi:10.1016/j.eurpolymj.2021.110357
Semitela, Â., Girão, A. F., Fernandes, C., Ramalho, G., Bdikin, I., Completo, A., et al. (2020). Electrospinning of bioactive polycaprolactone-gelatin nanofibres with increased pore size for cartilage tissue engineering applications. J. Biomater. Appl. 35, 471–484. doi:10.1177/0885328220940194
Shahrousvand, M., Haddadi-Asl, V., and Shahrousvand, M. (2021). Step-by-step design of poly (ε-caprolactone) /chitosan/Melilotus officinalis extract electrospun nanofibers for wound dressing applications. Int. J. Biol. Macromol. 180, 36–50. doi:10.1016/j.ijbiomac.2021.03.046
Shahrousvand, M., Hajikhani, M., Nazari, L., Aghelinejad, A., Shahrousvand, M., Irani, M., et al. (2022). Preparation of colloidal nanoparticles PVA-PHEMA from hydrolysis of copolymers of PVAc-PHEMA as anticancer drug carriers. Nanotechnology 33, 275603. doi:10.1088/1361-6528/ac6089
Shirzaei Sani, I., Rezaei, M., Baradar Khoshfetrat, A., and Razzaghi, D. (2021). Preparation and characterization of polycaprolactone/chitosan-g-polycaprolactone/hydroxyapatite electrospun nanocomposite scaffolds for bone tissue engineering. Int. J. Biol. Macromol. 182, 1638–1649. doi:10.1016/j.ijbiomac.2021.05.163
Sun, H., Mei, L., Song, C., Cui, X., and Wang, P. J. B. (2006). The in vivo degradation, absorption and excretion of PCL-based implant. Biomaterials 27 (9), 1735–1740. doi:10.1016/j.biomaterials.2005.09.019
Tajdari, A., Babaei, A., Goudarzi, A., Partovi, R., and Rostami, A. J. P. C. (2021). Hybridization as an efficient strategy for enhancing the performance of polymer nanocomposites. Polym. Compos. 42 (12), 6801–6815. doi:10.1002/pc.26341
Van der Schueren, L., Steyaert, I., De Schoenmaker, B., and De Clerck Kjcp, (2012). Polycaprolactone/chitosan blend nanofibres electrospun from an acetic acid/formic acid solvent system. Carbohydr. Polym. 88 (4), 1221–1226. doi:10.1016/j.carbpol.2012.01.085
Varshosaz, J., Sajadi-Javan, Z. S., Kouhi, M., and Mirian, M. (2021). Effect of bassorin (derived from gum tragacanth) and halloysite nanotubes on physicochemical properties and the osteoconductivity of methylcellulose-based injectable hydrogels. Int. J. Biol. Macromol. 192, 869–882. doi:10.1016/j.ijbiomac.2021.10.009
Wanjun, T., Cunxin, W., and Donghua, C. (2005). Kinetic studies on the pyrolysis of chitin and chitosan. Polym. Degrad. Stab. 87 (3), 389–394. doi:10.1016/j.polymdegradstab.2004.08.006
Xu, J., Zhang, J., Gao, W., Liang, H., Wang, H., and Li, J. (2009). Preparation of chitosan/PLA blend micro/nanofibers by electrospinning. Mater. Lett. 63 (8), 658–660. doi:10.1016/j.matlet.2008.12.014
Yin, J., and Xu, L. (2020). Batch preparation of electrospun polycaprolactone/chitosan/aloe vera blended nanofiber membranes for novel wound dressing. Int. J. Biol. Macromol. 160, 352–363. doi:10.1016/j.ijbiomac.2020.05.211
Zhang, T., Nie, M., and Li, Y. (2022). Biotechnology. Current advances and future perspectives of advanced polymer processing for bone and tissue engineering. Morphol. Control Appl. 10, 895766. doi:10.3389/fbioe.2022.895766
Zhu, J., Ye, H., Deng, D., Li, J., and Wu, Y. (2020). Electrospun metformin-loaded polycaprolactone/chitosan nanofibrous membranes as promoting guided bone regeneration membranes: Preparation and characterization of fibers, drug release, and osteogenic activity in vitro. J. Biomater. Appl. 34 (9), 1282–1293. doi:10.1177/0885328220901807
Keywords: polycaprolactone (PCL), chitosan, zinc oxide, curcumin, wound dressing, drug release, antibacterial activity
Citation: Mosallanezhad P, Nazockdast H, Ahmadi Z and Rostami A (2022) Fabrication and characterization of polycaprolactone/chitosan nanofibers containing antibacterial agents of curcumin and ZnO nanoparticles for use as wound dressing. Front. Bioeng. Biotechnol. 10:1027351. doi: 10.3389/fbioe.2022.1027351
Received: 24 August 2022; Accepted: 09 September 2022;
Published: 23 September 2022.
Edited by:
Yasser Zare, Motamed Cancer Institute, IranReviewed by:
Sayed Behnam Abdulahi, University of Tehran, IranJafar Khademzadeh Yeganeh, Qom University of Technology, Iran
Copyright © 2022 Mosallanezhad, Nazockdast, Ahmadi and Rostami. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Hossein Nazockdast, bmF6ZGFzdEBhdXQuYWMuaXI=